Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 503 | 9906 | SH | SOLE | 25 | 9906 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 274 | 5389 | SH | SOLE | 23 | 5389 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 100742 | 1982728 | SH | SOLE | 22 | 1937469 | 0 | 45259 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 164697 | 3241435 | SH | SOLE | 21 | 3241435 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 12780 | 251529 | SH | SOLE | 19 | 251529 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 10765 | 211859 | SH | SOLE | 18 | 203049 | 0 | 8810 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 48 | 941 | SH | SOLE | 7 | 941 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 11 | 226 | SH | SOLE | 4 | 226 | 0 | 0 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2874 | 56565 | SH | SOLE | 2 | 33116 | 0 | 23449 | May 13th, 2022 01:20AM | May 13th, 2022 01:20AM | Apellis Pharmaceuticals | |||
nasdaq:apls | nasdaq:apls Shareholders | 13F-HR | 0000831001-22-000081 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | CITIGROUP INC | 831001 | APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 620 | 12200 | SH | Call | DFND | 9,12,13 | 12200 | 0 | 0 | May 13th, 2022 01:16AM | May 13th, 2022 01:16AM | Apellis Pharmaceuticals |